We are live on
!
Find out more
Atara Biotherapeutics
ATRA
ATRA
116 hedge funds and large institutions have $1.01B invested in Atara Biotherapeutics in 2019 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 52 increasing their positions, 23 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
169% more call options, than puts
Call options by funds: $4.18M | Put options by funds: $1.56M
126% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 23
0.11% more ownership
Funds ownership: 4.23% → 4.34% (+0.11%)
8% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 25
3% less funds holding
Funds holding: 120 → 116 (-4)
48% less capital invested
Capital invested by funds: $1.94B → $1.01B (-$928M)
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Holders
116
Holders Change
-4
Holders Change %
-3.33%
% of All Funds
2.52%
Holding in Top 10
1
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-75%
% of All Funds
0.02%
New
23
Increased
52
Reduced
23
Closed
25
Calls
$4.18M
Puts
$1.56M
Net Calls
+$2.62M
Net Calls Change
-$2.79M
Top Buyers
| 1 |
MC
Maverick Capital
Dallas,
Texas
|
+$38.4M |
| 2 |
Morgan Stanley
New York
|
+$20.2M |
| 3 |
State Street
Boston,
Massachusetts
|
+$17.6M |
| 4 |
BG
Baupost Group
Boston,
Massachusetts
|
+$17.5M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$10.3M |
